BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15966843)

  • 1. What can proteomic analyses contribute to understanding the molecular biology and clinical behavior of prostate cancer?
    Ware JL
    Expert Rev Proteomics; 2004 Dec; 1(4):485-92. PubMed ID: 15966843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic technologies and their application to pancreatic cancer.
    Vimalachandran D; Costello E
    Expert Rev Proteomics; 2004 Dec; 1(4):493-501. PubMed ID: 15966844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK; Tyson DR
    Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin effects on the proteome of the LNCaP cell-line.
    Liu Z; Bengtsson S; Krogh M; Marquez M; Nilsson S; James P; Aliaya A; Holmberg AR
    Int J Oncol; 2007 May; 30(5):1173-9. PubMed ID: 17390019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
    Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
    Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing urologic diseases by proteomic techniques.
    Lee SW; Lee KI; Kim JY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):203-13. PubMed ID: 15652810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to proteomic analysis of human tumors.
    Ahram M; Emmert-Buck MR
    Methods Mol Biol; 2003; 222():375-84. PubMed ID: 12710699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach.
    Qingyi Z; Lin Y; Junhong W; Jian S; Weizhou H; Long M; Zeyu S; Xiaojian G
    Cancer Invest; 2009 Aug; 27(7):794-801. PubMed ID: 19637042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel proteomic approaches for tissue analysis.
    Tangrea MA; Wallis BS; Gillespie JW; Gannot G; Emmert-Buck MR; Chuaqui RF
    Expert Rev Proteomics; 2004 Aug; 1(2):185-92. PubMed ID: 15966813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteome analysis of prostate cancer.
    Kuruma H; Egawa S; Oh-Ishi M; Kodera Y; Maeda T
    Prostate Cancer Prostatic Dis; 2005; 8(1):14-21. PubMed ID: 15477873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics in the analysis of prostate cancer.
    Naaby-Hansen S; Nagano K; Gaffney P; Masters JR; Cramer R
    Methods Mol Med; 2003; 81():277-97. PubMed ID: 12725127
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].
    Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics and physiology of erythritol-producing strains.
    Park YC; Lee DY; Lee DH; Kim HJ; Ryu YW; Seo JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):251-60. PubMed ID: 15652814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-dimensional capillary electrophoresis and chromatography for proteomic analysis.
    Gao M; Zhang X
    Methods Mol Biol; 2008; 384():783-801. PubMed ID: 18392595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From proteins to proteomics.
    Bradshaw RA; Burlingame AL
    IUBMB Life; 2005; 57(4-5):267-72. PubMed ID: 16036609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics of mitochondrial inner and outer membranes.
    Distler AM; Kerner J; Hoppel CL
    Proteomics; 2008 Oct; 8(19):4066-82. PubMed ID: 18763707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
    Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
    Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An introduction into proteomics and its clinical applications.
    Ahram M
    Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.